ACE-Inhibitors NOT Associated With Early Severe #COVID-19 Disease- Breaking Research With Worldwide Implications Thanks To Digital Health

in ,

Breaking research from King's College Hospital​ London shows that ACE-inhibitors are NOT associated with early severe COVID-19 disease.

This is groundbreaking with immediate worldwide implications as it shows that patients do NOT need to stop their antihypertensives, which is in contrast to initial anecdotal reports from other sites during the early days of the pandemic.

This means our patients will NOT have to then present to hospital with hypertensive crises; heart attacks; stroke; or otherwise due to stopping their ACE-inhibitors, which would have substantially added burden to already strained healthcare systems worldwide. Patients will continue to benefit from the cardioprotective remodelling effects of these medications, and can safely continue them even if infected with coronavirus.

The speed of this research was greatly aided by digital health platform CogStack, which enables natural language processing to effectively mine data for medical research.

Congratulations to everyone involved! Please Help the global fight against COVID-19 by sharing this research.